trimethoprim--sulfamethoxazole-drug-combination and Atrophy

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Atrophy* in 2 studies

Other Studies

2 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Atrophy

ArticleYear
Pediatric atrophic rhinosinusitis: what can we do?
    International journal of pediatric otorhinolaryngology, 2015, Volume: 79, Issue:5

    A 5-year-old female had history of chronic foul smelling nasal discharge. Rhinoscopy showed greenish crusts lining the nasal cavities and inferior turbinates were shriveled significantly. Nasal cavity cultures of crusts by swab revealed Klebsiella ozaenae making the diagnosis of primary atrophic rhinosinusitis. After several unsuccessful treatment, we have decided to try sulfamethoxazole-trimethoprim prophylaxis and 1 year later there was a complete clinical improvement. There are many medical therapies and surgical options described, but none of them showed effective at long term. We present antibiotic prophylaxis as a viable alternative for long term control of the disease.

    Topics: Anti-Bacterial Agents; Atrophy; Child, Preschool; Endoscopy; Female; Humans; Klebsiella Infections; Nasal Cavity; Rhinitis; Sinusitis; Trimethoprim, Sulfamethoxazole Drug Combination; Turbinates

2015
Esophageal transplantation in the rat.
    Journal of pediatric surgery, 2013, Volume: 48, Issue:8

    Esophageal replacement surgery has been used to treat long-gap esophageal atresia, caustic esophageal stricture, and esophageal avulsion. Here, we report total esophageal transplantation in rats without vascular anastomosis as an option for esophageal replacement surgery.. Fourteen total segments of esophageal transplants were harvested from 24-week-old male Sprague-Dawley rats using a harvesting procedure. The segments were transplanted through the mediastinum in the esophageal bed of 15-week-old male Sprague-Dawley rats without adjacent vascular anastomosis using the transhiatal pull-up technique. The ends of the transplanted esophagus were ostomized using cervical and abdominal esophagostomies. An immunosuppressive-treated (IT) group (n = 7) received cyclosporine and cotrimoxazole for 10 days, while an untreated (UT) group (n = 7) received only cotrimoxazole for 10 days. On post-operative day 10, the rats were sacrificed, and the transplant and recipient esophagi were evaluated macroscopically and histopathologically.. All transplantations were successful and all transplanted rats survived. Upon macroscopic evaluation, no evidence of complications was observed and all transplanted esophagi in the two groups appeared to exhibit excellent firm tissue; however, mild necrosis was observed in the cervical end of the transplant in one rat in the IT group. Histopathologic examination showed a viable esophageal structure in all rats. Inflammation and muscular atrophy were lower in the IT group than in the UT group, whereas vascularity was higher in the IT group than in the UT group.. Total esophageal transplantation was performed directly without vascular anastomosis into recipients in a rat model. This procedure should be done in larger animal models before being attempted in humans.

    Topics: Anastomosis, Surgical; Animals; Anti-Bacterial Agents; Atrophy; Cyclosporine; Esophagitis; Esophagus; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Sprague-Dawley; Transplants; Trimethoprim, Sulfamethoxazole Drug Combination; Vascular Surgical Procedures; Wound Healing

2013